Callan Family Office’s iShares Russell 3000 ETF IWV Stock Holding History

Callan Family Office’s Portfolio IWV Stock Details IWV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Hold	3,156	–	–	0.03%	515
2026 Q1	$1.17M	Hold	3,156	–	–	0.03%	521
2025 Q4	$1.22M	Buy	+3,156	New	+$1.21M	0.03%	489

Other funds holding IWV

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SCM

SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return

AFI

American Family Investments Madison, Wisconsin $5.54B AUM 1.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UMC

UNC Management Company Chapel Hill, North Carolina $2.07B AUM 21.32% 1-Year Est. Return

PWA

Pitcairn Wealth Advisors Conshohocken, Pennsylvania $913M AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Callan Family Office's IWV Position: Q2 2026 in Review

Callan Family Office held its iShares Russell 3000 ETF (IWV) position steady in Q2 2026 at 3,156 shares worth $1.35M. The position accounts for 0.03% of the portfolio, ranked #515.

Callan Family Office first reported a position in IWV in Q4 2025 and has held it in 3 quarters since. 906 funds tracked by Wall St. Rank hold IWV as of Q2 2026.

Callan Family Office held 3,156 shares of iShares Russell 3000 ETF worth $1.35M as of Q2 2026.
Callan Family Office left its iShares Russell 3000 ETF share count unchanged in Q2 2026.
iShares Russell 3000 ETF made up 0.03% of Callan Family Office's portfolio in Q2 2026, its #515 holding.
Callan Family Office first reported a position in iShares Russell 3000 ETF in Q4 2025 and has held it in 3 quarters since.
906 funds tracked by Wall St. Rank held iShares Russell 3000 ETF as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.